On 22 December 2025, the Business & Human Rights Centre invited Cellebrite to respond to our guide for investors "Hidden risk is the most expensive: What investors need to know about high-risk surveillance technology".

For all of the allegations mentioned in the guide, companies had previously been contacted to provide a response either by the BHRC or the authors of the piece cited. However, we wanted to provide companies with the opportunity to give any updates on addressing individual cases or changes made at the systemic level to avoid similar cases from arising. Furthermore, we invited companies to respond to the due diligence questions (starting on page 31 of the guide) that responsible investors should ask of investee companies that develop or sell high-risk surveillance technologies.

Cellebrite representatives stated:

"Cellebrite is a proud global provider of digital investigative solutions to more than 7,000 public safety, defense, intelligence and private sector customers and assists in 1.5 million cases a year, including some of the most significant investigations of our time."

Cellebrite did not respond to any of the allegations, nor did they respond to the due diligence questions.